Perhaps more importantly is the fact that these CD6-CAR-T cells exhibited strong cytotoxicity against CRC cancer stem cells, indicating that CD6-CAR-T might be a promising treatment strategy for CRC (65). The gene discussed is CD6; the disease is colorectal carcinoma.